載入...
Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells
For metastatic bladder cancer patients, systemic cisplatin (CDDP)-based combination chemotherapy is the first-line choice of treatment. Although up to 70% of advanced bladder cancer patients initially show good tumor response to this form of combination chemotherapy, over 90% of good responders rela...
Na minha lista:
| 發表在: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7447157/ https://ncbi.nlm.nih.gov/pubmed/21964864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.26475 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|